摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-amino-3-(2-sulfanylidene-3H-1,3,4-thiadiazol-5-yl)urea | 955132-20-4

中文名称
——
中文别名
——
英文名称
1-amino-3-(2-sulfanylidene-3H-1,3,4-thiadiazol-5-yl)urea
英文别名
——
1-amino-3-(2-sulfanylidene-3H-1,3,4-thiadiazol-5-yl)urea化学式
CAS
955132-20-4
化学式
C3H5N5OS2
mdl
——
分子量
191.238
InChiKey
TWYZXRQRSYNTBL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.4
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    149
  • 氢给体数:
    4
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    5-溴靛红1-amino-3-(2-sulfanylidene-3H-1,3,4-thiadiazol-5-yl)urea溶剂黄146 作用下, 以 乙醇N,N-二甲基甲酰胺 为溶剂, 以78%的产率得到4-(4,5-dihydro-5-thioxo-1,3,4-thiadiazol-2-yl)-1-(5-bromo-2-oxoindolin-3-ylidene)semicarbazide
    参考文献:
    名称:
    Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity
    摘要:
    A new series of 1,3,4-thiadiazole-2-thione derivatives have been prepared and assayed for the inhibition of three physiologically relevant carbonic anhydrase (CA, EC 4.2. 1. 1) isozymes, the cytosolic human isozymes I and II, and the transmembrane, tumor-associated hCA IX. Against hCA I the investigated thiones, showed inhibition constants in the range of 2.55-222 mu M, against hCA II in the range of 2.0-433 mu M, and against hCA IX in the range of 1.25-148 mu M. Compound 5c, 4-(4,5-dihydro-5-thioxo-1,3,4thiadi izol-2-yl)-1-(5-nitro-2-oxoindolin-3-ylidene)semicarbazide showed interesting inhibition of the turnor-associated hCA IX with K-1 value of 1.25 mu M, being the first non-sulforiamide type inhibitor of such activity. This result is rather important taking into consideration the known antitumor activity of thiones. In addition, docking of the tested compounds into CA II active site was performed in order to predict the affinity and orientation of these compounds at the isozyme active site. The results showed similar orientation of the target compounds at CA II active site compared with reported sulfonamide type CAls with the thione group acting as a zinc-binding moiety. (C) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2007.07.044
  • 作为产物:
    描述:
    (5-thioxo-4,5-dihydro-[1,3,4]thiadiazol-2-yl)-carbamic acid ethyl ester一水合肼 作用下, 以 为溶剂, 反应 48.0h, 以84%的产率得到1-amino-3-(2-sulfanylidene-3H-1,3,4-thiadiazol-5-yl)urea
    参考文献:
    名称:
    Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity
    摘要:
    A new series of 1,3,4-thiadiazole-2-thione derivatives have been prepared and assayed for the inhibition of three physiologically relevant carbonic anhydrase (CA, EC 4.2. 1. 1) isozymes, the cytosolic human isozymes I and II, and the transmembrane, tumor-associated hCA IX. Against hCA I the investigated thiones, showed inhibition constants in the range of 2.55-222 mu M, against hCA II in the range of 2.0-433 mu M, and against hCA IX in the range of 1.25-148 mu M. Compound 5c, 4-(4,5-dihydro-5-thioxo-1,3,4thiadi izol-2-yl)-1-(5-nitro-2-oxoindolin-3-ylidene)semicarbazide showed interesting inhibition of the turnor-associated hCA IX with K-1 value of 1.25 mu M, being the first non-sulforiamide type inhibitor of such activity. This result is rather important taking into consideration the known antitumor activity of thiones. In addition, docking of the tested compounds into CA II active site was performed in order to predict the affinity and orientation of these compounds at the isozyme active site. The results showed similar orientation of the target compounds at CA II active site compared with reported sulfonamide type CAls with the thione group acting as a zinc-binding moiety. (C) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2007.07.044
点击查看最新优质反应信息